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Abstract
Background: A recent Dutch mono-centre randomised controlled trial has shown that
occupational therapy improves daily functioning in dementia. The aim of this present study is to
compare the effects of the Dutch community occupational therapy programme with a community
occupational therapy consultation on daily functioning in older people with mild or moderate
dementia and their primary caregivers in a German multi-centre context.
Methods/Design: A multi-centre single blind randomised controlled trial design is being used in
seven health care centres (neurological, psychiatric and for older people) in urban regions. Patients
are 1:1 randomised to treatment or control group. Assessors are blind to group assignment and
perform measurements on both groups at baseline, directly after intervention at 6 weeks and at
16, 26 and 52 weeks follow-up. A sample of 140 community dwelling older people (aged >65 years)
with mild or moderate dementia and their primary caregivers is planned. The experimental
intervention consists of an evidence-based community occupational therapy programme including
10 sessions occupational therapy at home. The control intervention consists of one community
occupational therapy consultation based on information material of the Alzheimer Society.
Providers of both interventions are occupational therapists experienced in treatment of cognitively
impaired older people and trained in both programmes. 'Community' indicates that occupational
therapy intervention occurs in the person's own home. The primary outcome is patients' daily
functioning assessed with the performance scale of the Interview for Deterioration in Daily Living
Activities in Dementia and video tapes of daily activities rated by external raters blind to group
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BMC Geriatrics 2009, 9:44 http://www.biomedcentral.com/1471-2318/9/44assignment using the Perceive, Recall, Plan and Perform System of Task Analysis. Secondary
outcomes are patients' and caregivers' quality of life, mood and satisfaction with treatment; the
caregiver's sense of competence, caregiver's diary (medication, resource utilisation, time of
informal care); and the incidence of long-term institutionalisation. Process evaluation is performed
by questionnaires and focus group discussion.
Discussion: The transfer from the Dutch mono-centre design to the pragmatic multi-site trial in
a German context implicates several changes in design issues including differences in recruitment
time, training of interventionists and active control group treatment.
The study is registered under DRKS00000053 at the German register of clinical trials, which is 
connected to the International Clinical Trials Registry Platform.
Background
Dementia is a progressive, irreversible neurodegenerative
disorder. The main symptoms are decline of memory and
other cognitive functions associated with deterioration in
daily functioning [1]. Several types of dementia are differ-
entiated by aetiology including 72% Alzheimer, 16% vas-
cular and 11% other types [2]. In the year 2000, there were
7.1 million people with dementia and 493 million per-
sons of working-age [3] within Europe. Age is associated
with increasing prevalence [4] with rates estimated at 6%
in people aged over 65 and 30% in the over 80s [5]. Inci-
dence rates range from 1.4% [6] to 3.2% [7]. Wancata and
colleagues [3] predict the number of people with demen-
tia in Europe to be 16 million or above in the year 2050.
Bickel [8] estimates these numbers for Germany at 1.2
million in 2010, 1.7 million in 2020 and 2.3 million in
2050. In Germany, more than two thirds of people with
dementia are women. 50% of community dwelling peo-
ple with need of nursing care suffer from dementia. The
disease constitutes the main cause of admission to long-
term nursing homes with 60% of nursing home residents
being affected by dementia. However, in Germany the
majority of people with dementia (60%) live in the com-
munity and receive care by family members [9].
Direct costs of dementia in the year 2003 were estimated
at 156 billion USD worldwide and 60.5 billion USD in
the EU-25 region [10]. Direct costs in Germany amount to
5.6 billion Euros in the year 2002, including the major
part of 3.6 billion Euros for dementia care in nursing
homes [11]. Considering direct and indirect costs in Ger-
many, Hallauer et al. [12] calculated dementia costs of
43,767 Euros per year and per patient, divided into 2.5%
medical costs (medication, consultation, hospital stays),
29.6% nursing care costs and 67.9% costs borne by the
patients' families. International studies demonstrate sim-
ilar results and confirm the fact that family caregivers bear
the main burden of dementia [13,14].
Deficits in daily functioning are used as threshold criteria
in standardized diagnostic procedure [15,16]. Within the
progress of disablement, cognitive decline leads to limita-
tions in activities of daily living, which often affect the
quality of life of patient and caregiver [17]. The new Inter-
national Classification of Functioning, Disability and
Health [18] is based on the bio-psycho-social model of
health and consequently assumes that the negative impact
of cognitive deficits on activities can be diminished by
improving facilitation in the patients' physical and social
environment. The task performance of people with
dementia can be improved by reducing distraction and
arranging clear structures in the physical environment
[19]. Research on caregiver interventions provides evi-
dence that those educational and psychosocial
approaches targeting at the optimisation of the social
environment delay nursing home placement [20-22]. Tai-
loring the activity to patients' capability may enhance
activity engagement and reduce challenging behaviour
[23].
A Dutch intervention programme in dementia care sys-
tematically integrated environmental adaptations, sup-
port of caregivers as well as selecting and tailoring
everyday activities with regard to patients' occupational
preference and cognitive abilities [24]. This programme
demonstrated positive impacts on patients' daily func-
tioning, caregivers' sense of competence in interaction
with the patient, on quality of life and mood of both and
on costs of dementia care [25-28].
This article presents the design of the WHEDA study eval-
uating, whether (1) the positive results are replicable in a
German multi-centre context and (2) the results remain
stable in a prolonged follow up period. The methods are
reported according to the requirements and structure of
the CONSORT-statement including the extensions for
non-pharmacological [29,30] and pragmatic trials [31].Page 2 of 15
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Design
In this pragmatic non-pharmacological intervention trial,
a randomised controlled design is being used in seven
health care centres and has the following research aims:
Primary outcome
To compare the effects of a community occupational
therapy programme (COTP) with a community occu-
pational therapy consultation (COTC) on daily func-
tioning of older people with dementia.
Secondary outcomes
• To evaluate the effectiveness of the COTP on
patients' and caregivers' quality of life, mood and sat-
isfaction with treatment and on caregivers' sense of
competence and hours of care compared to those hav-
ing a COTC.
• To evaluate the cost of both interventions from a
societal perspective.
The intervention group receives ten sessions of occupa-
tional therapy during five weeks of one hour duration.
The control group receives one home consultation of one
hour duration by an occupational therapist within the
same period. Measurements for both groups are at base-
line before intervention (week 0), after intervention
(week 6) and at follow-up (week 16, 26 and 52). Measure-
ments of cognitive decline are applied one week before
baseline and at week 11 and week 21 after baseline.
Participants
The seven participating centres are located throughout
Germany in urban regions. The catchment areas of the
centres vary from about 70,000 to 700,000 inhabitants.
Five outpatient memory centres are participating and are
departments of university hospitals (one neurological
clinic, two psychiatric clinics and two geriatric centres).
One centre is part of a municipal hospital specialising in
geriatric medicine. The seventh centre, a neurological pri-
vate practice, collaborates with an occupational therapy
private practice. The WHEDA study centres have several
years of experience in providing outpatient dementia care
ranging from three to fifteen years. Their standard service
comprises diagnostic work-up for dementia and related
diagnoses as well as recommendation of risk reduction,
dementia medication and non-pharmacological treat-
ments. Study leaders of the centres are medical specialists
(psychiatrists, neurologists or geriatricians) with six to
thirteen years of experience in dementia care. The occupa-
tional therapists and assessors involved in the study have
a minimum of one year's professional experience with
older people or those who are cognitively impaired. The
assessors' professions are physician, psychologist, occupa-
tional therapist and nurse.
The inclusion criteria are as follows:
▪ Mild to moderate dementia of the type Alzheimer's
disease or mixed type diagnosed according to ICD-10
by physicians who are geriatric or geronto-psychiatric
specialists with more than five years of experience.
Diagnosis usually included lab investigations and CT
or MRI scan of the brain.
▪ Mini Mental State Examination (MMSE [32]) ranging
from 14 to 24.
▪ People dwelling at home either together with their
primary caregiver or the primary caregiver provides
care at least twice a week.
The exclusion criteria are:
▪ A score on the 30-items Geriatric Depression Scale is
> 12.
▪ The people are in major need of nursing care (level 2
and 3. In Germany special physicians and nurses
involved in allocation of sickness funds have the legal
mandate to evaluate the need of nursing care accord-
ing to criteria determined by law. They assign a patient
to one of four levels: 0 = best, no need, 3 = worst,
severe need [33]).
▪ Unstable medical conditions or severe behavioural
disturbances, which do not allow participation in the
study as judged by the physicians of the study centres.
Discontinuation criteria:
▪ Death of patient or primary caregiver
▪ Patient is admitted to a nursing home
▪ Development of unstable medical conditions or
severe behavioural disturbances as assessed by the
physicians of the study centres
Registration and ethical considerations
The study is registered under DRKS00000053 at the Ger-
man register of clinical trials, which is connected to the
International Clinical Trials Registry Platform of the WHO
http://www.who.int/ictrp and thus meets the demands of
the International Committee of Medical Journal Editors.
The study protocol has been approved by the medical eth-
ics committee of the University Hospital, Freiburg,Page 3 of 15
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tic intervention to be carried out in subjects, whose capa-
bilities to consent might not be possible every time.
Therefore, and because the proxy caregivers are also inter-
viewed, it was proposed that double written consent was
given, ie. both from person with dementia and his/her
caregiver.
Recruitment
A leaflet with consistent and consumer-friendly informa-
tion about the WHEDA study was prepared for the recruit-
ment procedure. The recruitment period lasted nine
months, from August 2008 to April 2009. Former and cur-
rent patients of the participating centres with mild to
moderate dementia were informed about the WHEDA
study during a routine visit at the study centre or via an
invitation letter. General practitioners and medical spe-
cialists who usually cooperate with the centres received
information about the WHEDA study via mail, e-mail or
telephone. Community nursing and dementia care serv-
ices also received information letters or a telephone call.
Several centres published information via the local press.
A meeting was arranged at each centre for eligible patients
and their primary caregivers together in order to receive
verbal and written information from the study physician
about the study protocol. This included the contents of
the two occupational therapy interventions, the randomi-
sation procedures and the kind and duration of measure-
ments. Within this, or at a further visit, the study
physician received written informed consent and full
agreement with the contents and procedures of the study
from both patients and primary caregivers. This was essen-
tial before allowing participation in the study.
Comparison with 'usual' dementia care
The characteristic of the study design, inclusion and exclu-
sion criteria as well as participating centres and recruit-
ment processes were determined in such a way, to assure
that the study sample and procedures are approximately
congruent with the structures and processes of usual
dementia care in Germany. For this and other reasons, the
design of the WHEDA study differs from the original
Dutch trial. There is a higher number of participating cen-
tres and therapists; less years of experience of the thera-
pists; as well as the inclusion of an active control
treatment arm, a longer follow up period and study sites
other than university centres.
The Intervention Group (COTP)
Intervention group participants receive COTP with ten
sessions of one hour duration held over five weeks. The
intervention aims at the improvement of daily function-
ing of both the patients and their primary caregivers. The
treatment of the patient focuses on enabling the successful
performance of highly meaningful daily activities. There-
fore, the occupational therapist explores the patient's pref-
erences and history of activities using the one hour
Occupational Performance History Interview [34]. In the
second session, the occupational therapist observes the
patient's ability to perform relevant daily activities and to
use compensatory strategies within his/her familiar envi-
ronment and then evaluates the possibility of modifying
the patient's home and surroundings if necessary.
The intervention focus for the caregiver is on enhance-
ment of successful interaction with the person with
dementia by improving the caregiver's skills in communi-
cation, supervision and problem solving. In addition, the
caregiver is supported in caring for his own wellbeing by
enabling meaningful and recreational daily activities.
Therefore, the occupational therapist explores the car-
egiver's preferences of activities using the one hour Ethno-
graphic Interview [35]. He/she also observes the
interaction between caregiver and patient.
After three or four sessions of interviews and observation
in the familiar surroundings, the occupational therapist
summarizes the meaningful activities that were named in
both the interviews with the patient and the caregiver.
Patient and caregiver together prioritise the proposed
activities. In discussion with the occupational therapist,
they identify those which are
• most meaningful and motivating for the patient
(patient's perspective)
• most helpful or recreational for the caregiver (car-
egiver's perspective)
• most promising to be adapted and stabilised as activ-
ities that the patient and caregiver can perform suc-
cessfully in the future (occupational therapist's
perspective)
When one or two of the most appropriate activities are
chosen, the therapist defines compensatory and environ-
mental strategies to adapt activities and environment to
the patient's habits and cognitive abilities if required.
Patient and caregiver are taught to use and optimize these
compensatory and environmental strategies to improve
their performance of daily activities. Therefore, the car-
egiver is trained in effective supervision skills and receives
practical and emotional support. In addition, the car-
egiver is taught effective problem solving and coping strat-
egies by means of cognitive and behavioural
interventions, in order to sustain the patient's and his/her
own autonomy and social participation. A manual com-
prising a detailed description of the intervention is used
[24]. These guidelines for the treatment of older people
with cognitive impairments has been developed and eval-
uated systematically over the last ten years. This processPage 4 of 15
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advisor panel of international experts, draft manuals,
pilot testing in practice, case study analyses, pilot study
and an RCT on effectiveness and on cost-effectiveness [25-
28,36]. For the WHEDA study, the Dutch manual was
translated into German. The main author (Maud Graff,
MG) taught the content of this manual to 14 study thera-
pists from seven centres in 16 hours of seminars. Seminar
methods included presentation, videos and role play with
feedback and group discussion. The study therapists had
to have at least one year of professional experience in the
treatment of older persons with cognitive impairments.
Within the pilot phase after the seminars, every therapist
had to treat at least one patient with a full treatment series
of ten sessions. The therapist also had to provide a video-
tape of one key session (interview with patient or car-
egiver or shared goal finding session) and a quality report
reflecting on the whole series. Videotapes were evaluated
by MG and quality reports by the study manager, Sebas-
tian Voigt-Radloff (SVR). The expenditure of time for the
seminars and learning on the job within the pilot phase
was about 40 hours per therapist while in the Netherlands
it was 80 hours including more skill training, learning on
the job and feedback.
The following arrangements were provided to enhance
and evaluate the adherence of the therapists to the man-
ual:
• A mailing list for e-mail exchange of all study thera-
pists and the study manager.
• On-call telephone coaching by SVR for the thera-
pists.
• Therapy evaluation form for every treatment case,
where therapists assess their adherence to the manual
and describe their problems within the eleven differ-
ent intervention steps.
• Questionnaire, by which therapists retrospectively
evaluate the whole intervention phase after it is fin-
ished.
• The study protocol demands adherence to the stand-
ard procedures of the manual. However, a therapist
may deviate from the manual in cases, where strict
adherence would lead to any harm to patient or car-
egiver; if very poor motivation; or to withdrawal. The
deviation must be reported on the therapy evaluation
form. In general, the manual sets standards for the
procedures, but an inherent part of the treatment is the
individualised tailoring of activities to patients' and to
caregivers' preferences and abilities. The demands for
adherence and rules for exceptions do not differ
between centres, therapists or participants.
In Germany, a series of ten home visits is within the nor-
mal range of time that occupational therapists use for the
treatment of older outpatients diagnosed with other dis-
eases, such as stroke or rheumatoid arthritis. A directive
governs the service delivery and utilisation of occupa-
tional therapy in German private practices. It gives per-
mission to do home visits, but they are not often used. No
additional legal or organisational structures are being
added for the new intervention programme. However,
home visits of occupational therapists working with peo-
ple with dementia are not established yet due to the lack
of evidence-based interventions in Germany. A seminar
and learning time of 40 hours is quite common in the
field of occupational therapy, in order to implement an
innovative intervention.
Control Group
The patients and care givers in the control group, together
receive one COTC of one hour's duration by the same
study therapists who carry out the treatment intervention.
The visit is not time-matched to the intervention group.
The control intervention is carried out as a semi-structured
consultation, half is an explanation using a brochure; and
half is a talk on individual problems in everyday life. Two
occupational therapists with a high level of experience in
dementia care prepared the brochure of ten pages espe-
cially for the WHEDA control intervention. It is based on
two brochures of the German Alzheimer Society [37,38].
During a three hour session, SVR taught the WHEDA ther-
apists the content of the control intervention, using pres-
entations and role plays. Within the pilot phase, the study
therapists of each centre have had to collect contact data
of dementia care services in their region and add it to the
brochure, which is then given to caregivers and patients
during the home consultation. Furthermore they are
obliged to carry out one full pilot COTC and write a qual-
ity report on problems and facilitation of this consulta-
tion visit. SVR evaluates this quality report. The protocol
of the control intervention was determined as follows:
• 10 minute warm-up phase including the welcome
and introduction of the scope and purpose of the con-
sultation;
• 20 minute structured explanation of how patients
and caregivers may deal with the consequences of
dementia in every day life;
The outcome for the patient is to:
 stay active, undertaking usual everyday activities
 keep social contacts
The outcome for the care giver is to:Page 5 of 15
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tive;
 take time for self;
 keep social contacts and look for support for self;
 discuss what a successful interaction with the
patient may look like, especially when challenging
behaviour occurs;
 use data of local dementia care services such as
day care clinics, caregiver or dementia outpatient
groups, outpatient nursing care, home help or
occupational therapy private practices.
• 25 minute talk on individual problems that arise
from the patients' and the caregivers' needs;
• 5 minute completion and farewell.
The focus of the control intervention is on the encourage-
ment to stay active in everyday life, keep social contacts
and use resources within the environment.
The same arrangements as in the intervention group are
provided to enhance and evaluate the therapists' adher-
ence to the structure and procedure of the introduction to
the control group. The control group protocol leaves the
occasional decision to the therapist, whether the 20
minute block with structured explanations is to be timed
before, after or in between, the talk on individual prob-
lems. Problems and deviations from protocol must be
documented in the therapy evaluation form. Rules of pro-
cedures and exceptions apply to therapists of all study cen-
tres in the same way.
Consultations of 30 minutes up to one hour duration are
common in German dementia care. However, social
workers, physicians or special nurses mainly give advice
on local care services, on progress and medication in
dementia and on nursing care problems. The focus on
occupational therapy and everyday activities is innovative,
but needs no additional resources.
Objectives
The aim of this study was to compare the effects of the
COTP and the COTC on functioning in everyday life of
people with mild or moderate dementia and their primary
caregivers within a German routine care context. The null
hypothesis is that there is no significant difference
between the intervention group and the control group.
The significance for rejecting this hypothesis will be tested
two-sided. The secondary research questions are as fol-
lows:
• Impact of COTP and COTC on the:
 quality of life of patients and caregivers
 mood of patients and caregivers
 caregivers' competence in the interaction with the
patients
 utilisation of resources for patients and caregivers
 time of informal care given by the primary car-
egivers
• Costs and feasibility of COTP and COTC
• Patients' and caregivers' acceptance and satisfaction
with COTP and COTC
• Incidence of admissions to long-term nursing care
homes one year after baseline
Outcomes
The primary endpoint is the comparison between the
intervention group and control group in the change in
daily functioning from baseline to follow-up as indicated
by the Interview for Deterioration in Daily Living Activi-
ties in Dementia (IDDD) over three post intervention
time points. The WHEDA measurement scheme with
dependent variables and measurement instruments is
provided in table 1. The primary and most secondary out-
comes are oriented to patient and caregiver. Daily func-
tioning, quality of life, mood and daily interaction are
directly related to individual everyday life and represent
the user's perspective in most self- and proxy-assessments
used in the WHEDA study. It is of great importance to
know how long a therapeutic approach may stabilise daily
functioning after the intervention is finished. The cogni-
tive decline in dementia is a strain on patients and caregiv-
ers. Its progress varies, but major and consistent changes
are mostly not observable before a half year progress of
disease. Consequently, the follow-up assessments are
appointed at week 16 and 26 after baseline. In order to
justify a potential implementation in practice, service pro-
viders as well as political and economical decision-makers
within the health care system need trustworthy evidence
about an innovative intervention. Hence feasibility,
acceptance and costs of active and control treatment are
additional outcomes of the WHEDA study.
The quality of the measurements is enhanced by an
extended check and report of metric properties and via fol-
lowing methods of process improvements:Page 6 of 15
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viewing patients, taking videotapes of patients' every-
day activities, handing over questionnaires to
caregivers and checking completed forms for com-
pleteness and plausibility.
• The main assessor of every study centre performs two
pilot assessments including videotaping and his/her
deputy performs one assessment.
• All questionnaires and video tapes of pilot assess-
ments and, additionally, a quality report reflecting
problems and facilitation within this pilot phase, are
sent to the WHEDA-headquarters. Video tapes are
evaluated by a rating specialist for the Perceive, Recall,
Plan and Perform System of Task Analysis (PRPP) and
questionnaires and quality reports by SVR. A positive
rating of all pilot material is required, in order to
achieve approval for starting the study.
• The 'blind' raters of the videos give feedback on visi-
bility and appropriateness of instructions on every
tape. Based on this feedback, the WHEDA headquar-
ters gives assessors recommendations for the improve-
ment of videotaping in case the visibility or
instructions are lower than the defined quality level.
• A mailing list for an online exchange of study asses-
sors has been established.
• Any problem with assessment arising during the
study is added to the problem solving list. Problems
Table 1: WHEDA measurement scheme
Week
Variable Instrument -1 0 6 11 16 21 26 32 38 45 52
Primary outcome
Patients' functioning in everyday life IDDD, PRPP-Video rating X X X X
Secondary outcome patient
Quality of life DQoL, SF-12 X X X X
Mood CSDD X X X X X
Resource utilisation incl. informal care Adapted RUD (+ diary as reminder) X X X X X X X X X X
Satisfaction with treatment 5-point-Likert-scale and comments X
Long-term institutionalisation Adapted RUD (+ diary as reminder) X X X X X X X X X X
Secondary outcome caregiver
Competence in interaction with patient SCQ X X X X X
Quality of life DQoL, SF-12 X X X X X
Mood CES-D X X X X X
Resource utilisation Adapted RUD (+ diary as reminder) X X X X X X X X X X
Satisfaction with treatment 5-point-Likert-scale and comments X
Control measures
Demographic data Socio-demographic questionnaire X
Depression GDS X
Cognition MMSE X X X
Medication Adapted RUD (+ diary as reminder) X X X X X X X X X X
Periods of illness Adapted RUD (+ diary as reminder) X X X X X X X X X X
Process measures
Adherence to manual (therapist) Evaluation form for every treatment X
Adherence of patient and caregiver Structured therapist questionnaire When treatment period is finished
Adherence to protocol (therapist) Structured therapist questionnaire When treatment period is finished
Adherence to protocol (study centres) Deviations of protocol schedule Continuous registration
IDDD = Interview of Deterioration in Daily Living Activities in Dementia
PRPP = Perceive, Recall, Plan and Perform System of Task Analysis
DQoL = Dementia Quality of Life Instrument
SF-12 = Short Form of the SF-36 measuring health-status
CSDD = Cornell Scale for Depression in Dementia
RUD = Resource Utilization in Dementia
SCQ = Sense of Competence Questionnaire
CES-D = Center for Epidemiologic Depression Scale
GDS = Geriatric Depression Scale
MMSE = Mini Mental State ExaminationPage 7 of 15
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solving are given by SVR via this list, which is sent out
to the study centres as soon as a new item is added.
Primary outcome measures
• The Interview of Deterioration in Daily Living Activ-
ities in Dementia (IDDD [39]) consists of two scales
recording the caregivers' rating of patients' initiative
and performance of daily living activities. The Initiative
Scale measures the initiative for (1) washing oneself,
(2) making tea or coffee, (3) dressing, (4) combing
one's hair and brushing one's teeth, (5) shopping, (6)
using the phone, (7) preparing a meal, (8) cleaning
the house or doing minor repair work and (9) han-
dling finances. The Performance Scale records the need
of assistance in the performance of the same nine
activities plus eating and using the toilet. Both
domains of the IDDD are constructed as five-point-
Likert-scales with the ratings never = 4, seldom = 3,
sometimes = 2, often = 1, always = 0 in the Initiative
Scale and values vice versa in the Performance Scale.
Scores of the Initiative Scale range from 0 to 36 (higher
scores indicate less initiative). The Performance Score
ranges from 0 to 44 (higher scores indicate higher
need for assistance). In a Spanish sample of 451 per-
sons, the IDDD demonstrated great internal consist-
ency (Cronbach's alpha = .99), reproducibility
(intraclass correlation coefficient ICC = .94) and sig-
nificant differences between groups of patients with
mild cognitive impairment and patients with demen-
tia [40]. In a Dutch sample of 25 primary and second-
ary caregiver pairs, the IDDD interrater reliability was
high (ICC: .85 for the Initiative Scale and .74 for the
Performance Scale, [39]). Within the Dutch original
study the Performance Scale demonstrated a very high
responsiveness by indicating clinically relevant
improvement in 78% of cases in the intervention
group and 12% of cases in the control group 6 weeks
after baseline and 82% and 10% respective after 12
weeks [26].
• With the Perceive, Recall, Plan and Perform System
of Task Analysis (PRPP) occupational therapists evalu-
ate a usual daily activity as performed by the patient as
well as the impact of the cognitive performance com-
ponent on this performance [41]. In the first of two
assessment stages, the rater defines single steps of the
performed activity to be analysed and identifies any
activity step in which errors of accuracy, omission, rep-
etition or timing occur. The number of activity steps
rated as incorrectly performed is divided by the total
number of activity steps, resulting in an independ-
ence-score indicated in percent (100% = all steps are
error-free). In the second stage, the therapist rates 34
items of observable behaviour representing the
patients' use of information processing strategies
while performing the activity. On the three-point-Lik-
ert-scale the value 1 indicates incomplete or non-
timely or jeopardising task performance or the need of
significant assistance. Value 2 indicates a complete
and non-jeopardising task performance but with
problems in timing and possible need of assistance.
Value 3 indicates a complete, timely and non-jeopard-
ising task performance without any need of assistance.
The 34 unweighted items are summed up by four
main scales Perceive, Recall, Plan and Perform each
with three subscales and a PRPP global processing
score ranging from 35 to 103 (higher scores denotes
better performance). The PRPP-System was systemati-
cally developed over the last 12 years including the fol-
lowing steps and results [41]:
 Content validity was shown in a comparative
analysis of the same activities of daily living in a
sample of 25 healthy adults and a sample of 20
persons with brain injury. Variations of individual
performance but no errors occurred within the
healthy sample whereas clearly observable errors
within the sample with brain injury could be cata-
logued in the four main categories accuracy, omis-
sion, repetition or timing. Interrater agreement of
six raters was high (>90%) for both samples.
 A microanalysis of more than 4000 errors occur-
ring in the performance of dressing, eating and
grooming of 45 patients with brain injury revealed
four broad errors types in cognitive processes of
perceiving, recalling, planning and performing.
Error analyses in subsequent investigations of
other samples led to a stable pattern of 34 items
which describe observable behaviour.
 Aubin et al. [42] found moderate indicators for
the construct validity of the PRPP in a small sam-
ple of 10 adults with schizophrenia. The scores of
the PRPP total and three of four scales differed sig-
nificantly comparing a simple and a complex activ-
ity of meal preparing (p ≤ .01). The correlation
between PRPP global score on the complex task
and the Independent Living Skills Survey [43] was
moderate (r = .67, p = .03).
 Interrater reliability of three raters in a sample of
15 adults with schizophrenia was moderate (ICC:
PRPP total .77, Perceive .65, Recall .65, Plan .69, Per-
form .63 [42]). An investigation of interrater relia-
bility of nine raters in a sample of five adults with
brain injury and symptoms of agitation and confu-
sion demonstrated similar results (ICC: PRPP total
.60, Perceive .59, Recall .59, Plan .51, Perform .53Page 8 of 15
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retest reliability and high internal consistency (ICC
> .8).
 A high responsiveness of the instrument was indi-
cated by significant improvement and large treat-
ment effects as measured by the PRPP in seven
adults with post-traumatic amnesia and symptoms
of agitation [45].
Within the WHEDA-study, videotapes of two activities
familiar to the patient and chosen out of a list of 28
defined activities of daily living are scored with the PRPP.
Less and more difficult variations are described for every
activity and can be applied according to the patient's cog-
nitive ability. The WHEDA assessors must document the
variant, which is noted at the first measurement time
point and initiate and tape this variant at the follow up
measurements.
Secondary outcome measure
• The Dementia Quality of Life Instrument (DQoL) is
a 30-item self-assessment. 5 subscales and one global
item are assessed with a five-point-Likert-scale: positive
affect (6 items), negative affect (11 items), feelings of
belonging (3 items), self-esteem (4 items), and sense of
aesthetics (5 items). The ranges of scores differ from
scale to scale (from 5-15 to 5-55). Higher scores indi-
cate better quality of life, except in the subscale nega-
tive affect. The DQoL was developed specifically to be
completed by people with dementia. The develop-
ment process included consultation with people with
dementia, caregivers, and professional care providers.
In an American sample, 96% of 99 people with
dementia (MMSE > = 13) were able to respond to
questions appropriately [46]. This study revealed
moderate to high internal consistency (.67 - .89) and
a good two-week test-retest reliability (.64 - .90). There
were no significant differences between patient groups
with mild (MMSE > 17) and moderate (MMSE < = 17)
dementia severity in terms of scale reliability. Correla-
tion of DQol subscales and the Geriatric Depression
Scale ranged from -.42 to -.64. A Japanese study repli-
cated similar results for understanding, internal con-
sistency and convergent validity at baseline and in a
one year follow up. The sample consisted of 72 people
with dementia with MMSE score > = 13 [47,48]. In a
British study on longitudinal change in quality of life,
60% of people with a MMSE of 10 could complete the
DQoL [49]. In an American study with 67 patients
diagnosed with mild cognitive impairment or mild
Alzheimer's disease, a three-factor solution emerged
reliably from factor analyses corresponding to positive
affect, negative affect and aesthetics. This DQoL factor
structure was nearly identical between ratings of
patient and caregiver [50]. Within the WHEDA study,
the DQoL is applied to primary caregivers as self-
assessment. With the patients, it is performed as an
interview, in order to ensure the validity of rating.
Patients are asked to answer three screening questions
and data will not be collected, if more than one answer
is missing.
• The SF-12 is the reduced version of the SF-36, a
generic self-assessment evaluating health status and
disability. The instrument generates a mental and a
physical component summary score from 12 weighted
items with response categories varying from dichoto-
mous, to six-point scales using a complex algorithm
based on norm data of a major American sample.
Higher scores indicate better health status. Metric
properties are excellent [51] and German norm data
are available [52]. The instrument supports the calcu-
lation of Quality Adjusted Life Years (QALY). The SF-
12 has been applied to people with dementia recently
[53] and to caregivers [54]. The SF-12 appears to iden-
tify under-reported mental health problems in demen-
tia caregivers [54]. In addition, this assessment tool
seems to be appropriate for the evaluation of health-
related quality of life from both the caregiver's and the
patient's perspective. Arlt and colleagues [53] found
that family caregivers tend to rate the patient's health-
related quality of life lower than the person with
dementia him/herself. For that reason the SF-12 is
applied in the WHEDA-study to both the caregiver and
the patient. In order to ensure quality of patients' data,
the WHEDA-assessor applies the SF-12 as an interview
to the patient and checks his/her understanding by
means of the DQoL screening questions.
• In the Sense of Competence Questionnaire (SCQ
[55]), caregivers rate their agreement with 27 state-
ments on the experience of caregiving on a five-point-
Likert-scale (from agree very strongly to disagree very
strongly). The SCQ records three domains: Conse-
quences of involvement in care for the personal life of the
caregiver (8 items), satisfaction with one's own perform-
ance as a caregiver (12 items) and satisfaction with the
person with dementia as a recipient of care (7 items).
Scores range from 27 to 135 (higher scores denote a
greater sense of competence). The three domains of
the SCQ and its internal consistency are confirmed in
validation studies involving people with stroke and
dementia (variance explained by three factors: 49%
respective 42%, Cronbach's alpha: .68 - .77, .83 - .85
respectively [56,57].
• The Center for Epidemiologic Depression Scale
(CES-D) [58] is frequently used to evaluate mood and
depression levels of persons caring for patients withPage 9 of 15
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20 symptoms on a four-point Likert Scale (from seldom
to mostly). Scores range from 0-60, lower scores indi-
cate less depressive indicators. Robust metric proper-
ties of the CES-D are established [63]. Correlations
with Hamilton Depression Scale and Becks Depres-
sion Inventory are moderate to high (.49 to .94). Sen-
sitivity to change in individuals within samples treated
with anti-depressive drugs was significant (.0001 to
.0004). Cronbach's alpha of .89 indicates high inter-
nal consistency. In the WHEDA study, the CES-D is
applied as self-assessment.
• With the Cornell Scale for Depression in Dementia
(CSDD), the caregiver rates 19 symptoms of the
patient within four domains: (1) mood and related signs
(2) behavioural disturbance (3) cyclic function and idea-
tional disturbance and (4) physical signs [64]. All 19
symptoms are rated on a three-point continuum:
'absent', 'mild or intermittent' or 'severe'. Scores range
from 0-38, lower scores indicate less depressive char-
acteristics, nine or more points indicate a depressive
disorder. Müller-Thompsen et al. [65] found signifi-
cant high correlations between the CSDD and three
other scales for depression in a sample of patients with
mild Alzheimer Disease (Geriatric Depression Scale:
.70; Montgomery and Åsperg Depression Scale: .93;
Nurses Observation Scale for Geriatric Patients, Mood:
.72) and high correlations with the Montgomery and
Åsperg Depression Scale (.74) in the more severely
impaired group. Cronbach's alpha of .81 and .82 indi-
cated high internal consistency in both, the mild and
severe dementia group. The validation study of Korner
and colleagues [66] revealed high inter-rater reliability
for a sub-sample of 15 people with dementia video-
taped and rated by independent raters (ICC: .84). Lam
et al. [67] compared four depression scales in 88 eld-
erly outpatients with dementia. They found different
cut-off values for sensitivity and specificity of the
CSDD in subgroups of patients with mild (91.7%,
80% respectively, cut off 6/7) and moderate to severe
dementia (70%, 87% respectively, cut off 12/13).
• The primary caregiver provides data on his/her own
and the patient's resource utilization in a self- and
proxy-report (adapted Resource Utilization in Demen-
tia RUD [68]). The adapted RUD records resource uti-
lization in the following fields:
 a. Medical care for the patient: (1) periods of ill-
ness, nights in hospital or nursing home, number
of consultations and purchase of technical aids
within the last six weeks. (2) Number and duration
of therapy sessions (such as physical or psycho-
therapy), nursing care or home care and visits to
day care groups within the last two weeks;
 b. Informal care for the patient: (1) Hours per day
of the primary caregiver for assistance in activities
of daily living, instrumental activities of daily liv-
ing and supervision; and also hours per day the
patient is without supervision. (2) Hours of super-
vision by others, informal or professional caregiv-
ers within the last two weeks (as recommended by
Neubauer et al. [69]);
 c. Medication of the patient within the last two
weeks;
 d. Medical care for the caregiver: (1) periods of ill-
ness, nights in hospital or nursing home, number
of consultations and purchase of technical aids
within the last six weeks. (2) Number and duration
of therapy sessions, nursing care or home care, vis-
its to groups for caregivers of people with dementia
within the last two weeks;
 e. Amount of work per week and days absence
from work of the primary caregiver;
 f. Medication taken by the primary caregiver
within the last two weeks.
Wimo and Nordberg [70] found fair to high correlations
between times of caregiving as observed by a special team
and estimated in RUD by the caregivers in twenty institu-
tionalized persons with dementia (correlation coefficients
in ADL-time .81, p < .001; in IADL .29, p = .03; supervision
.51, p < .001). In the WHEDA-study, the adapted RUD is
applied at every measurement time point after recruit-
ment, in order to record the full resource utilization until
the one year follow up. For supporting the retrospective
data collection, the caregiver keeps a diary of periods of
illness, nights in hospital or nursing home, number of
consultations and purchase of technical aids.
• Patient and caregiver rate their satisfaction with
experimental and control treatment on a five-point
Likert scale on five items: How (1) patient, (2) sympa-
thetic and (3) encouraging was the therapist? How
much did the treatment deal (4) with your everyday
life and (5) goals that are important to you? How sat-
isfied are you in general with the treatment? The ques-
tionnaire also asks for comments and suggestions.
Control measures
• The Sociodemographic Questionnaire provides data
on the patient's and primary caregiver's age, sex, socio-
economic and educational status, relation betweenPage 10 of 15
(page number not for citation purposes)
BMC Geriatrics 2009, 9:44 http://www.biomedcentral.com/1471-2318/9/44patient and caregiver and their housing. It is a self- and
proxy-report of the primary caregiver.
• The study physician evaluates the patient's cognitive
status using the Mini Mental State Examination, a
broadly applied performance test with established
metric properties [32]. The MMSE ranges from 0 to 30.
The higher the score the better the cognitive status.
• The Geriatric Depression Scale (GDS [71]) is a self-
rating scale consisting of 30 questions to be answered
dichotomously as 'yes' and 'no'. The GDS score ranges
from 0 to 30; higher scores indicate major depressive
indicators. The cut-off point for depression is 12. Cor-
relation of GDS and CSDD scores was .70 in a German
sample of 140 patients with mild dementia [65]. The
authors found sufficient internal consistency in sub-
groups of patients with mild (MMSE ≥ 18) and mod-
erate to severe (MMSE<18) dementia (Cronbach's
alpha: .83, .74 respectively).
Process measures
• Problems during treatment and adherence to the
manuals are recorded by an evaluation form for every
treatment case in both study groups.
• The study therapists evaluate their adherence to the
study protocol as well as barriers and facilitators of the
treatment process within a self-report questionnaire
for the relevant period (seminar, pilot phase, treat-
ment series). In addition, this questionnaire collects
the therapists' ratings and comments on the adherence
of patients and caregivers to therapeutic recommenda-
tions (interventions group only, since follow up visits
are missing in control group and control for adherence
is not possible). The summarised self-report results are
reflected in a focus group discussion for all therapists
involved in the study.
• Further indicators of adherence to protocol are the
numbers of treatments, assessments and medical con-
trol visits inside, versus outside, the protocol schedule.
Additionally, the completeness of measurements at
every time point is evaluated (eg. videotape or patient
interview might be missing due to reduced cognitive
capacity).
Sample size
Although the Dutch original randomised control trial [26]
found very large effect sizes on the performance scale of
the Interview of Deterioration in Daily Living Activities in
Dementia (at 12 weeks follow-up d-value = 2.4), the
power of the WHEDA-study is calculated conservatively in
order to detect small effects. The rationale is the change in
design; that there is an active control treatment, less pro-
fessional experience in the experimental treatment in Ger-
many, less patients per therapist and a longer follow-up in
a sample with expected progress in dementia, may reduce
the expected effects. The power calculation is based on an
analysis of variance of two groups and four measurement
time points (since in the postal follow up at 52 weeks the
IDDD is recorded, too). Hypothesising an alpha of .05
(two-sided), a power of .80 and a correlation of .7
between four measurement time points, a sample of 84
persons is needed, in order to detect an effect of f = .10
[72]. According to drop out rates of the Dutch study, 280
patients must be screened and 140 recruited (see figure 1).
Randomisation
After the recruitment of an individual, the physician of the
study centre e-mailed the request of randomisation to a
statistician at a distant site. The physician also informed
the assessor (and optionally a co-ordinator of the study
centre) and asked him/her to schedule all assessment
dates according to the protocol. After the referral by the
centre physician, the independent statistician allocated
the individual to COTP or COTC. The randomisation
sequence was computer-generated with blocking by cen-
tre and groups of two persons, without stratification and
in a ratio of 1:1. Group allocation was e-mailed to the
therapists at the study centre. The therapists decided who
would be responsible for this case and the lead therapist
confirmed reception of group allocation to the independ-
ent statistician. In addition, the lead therapist informed
his centre team that he had received group allocation. In
order to avoid any contamination, the centre therapists
must schedule treatment sessions on their own. He/she
also has to fax the records to the WHEDA-headquarters
and retain their records, strictly separated from any other
centre staff. Masking of patients and caregivers is not pos-
sible due to the different quantity of home visits between
intervention and control group. Assessors might be con-
taminated by hints of patients or caregivers during the
assessments at home. Assessors, patients and caregivers
are asked to avoid any talks about the treatment. The
extent of assessor 'blinding' will be evaluated by the com-
parison of actual group assignment and the assessor's esti-
mation of group assignment. The procedure of video-
rating ensures the full 'blinding' of the Dutch raters of an
individual's assignment to group. Independent staff of the
WHEDA-headquarters check and 'clean' the videotapes
from any hint of group assignment or personal data,
before the tapes are transferred to the Netherlands.
Statistical methods
Data are entered via special MS Access entry masks auto-
matically controlling for data plausibility. In addition,
sections of entered data are checked for typing errors by
hand, in order to ensure an error rate lower than 0.2%.
Baseline measures and demographics of participants sig-Page 11 of 15
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group and control measures are used as co-variates in an
analysis of variance with repeated measures with two
groups and four measurement time points. If the diagno-
sis of extent and type of missing data reveal that the pre-
condition is given, the Full Information Maximum
Likelihood (FIML) method will be applied for data
replacement [73]. The primary intention-to-treat analysis,
including all participants with valid data (whether they
did or did not receive the intervention), will be compared
with a per protocol analysis excluding all participants with
documented deviations from the protocol (ie. not receiv-
ing the entire intervention or receiving an incomplete fol-
low-up). The comparison of these groups will be adjusted
for baseline imbalance and process variations. Variations
in the adherence to protocol; to the treatment manual and
to therapeutic recommendations; variations in medica-
tion and progress of cognitive decline as well as variations
in the quality of supporting or hindering structures and
processes at the study sites are considered as possible
mediators. All statistical tests will be two-sided on an
alpha level of .05.
Discussion
The WHEDA-study evaluates whether the improved
effects on daily functioning in people with dementia,
found in a Dutch RCT within a community occupational
therapy programme, can be replicated in a single blind
German randomised controlled multi-centre design with
prolonged follow-up assessment. The transfer from the
Dutch mono-centre design to the pragmatic multi-site
trial in a German context implicated several determina-
tions in design issues.
 1. The decision for a multi-centre design is justi-
fied by a short time frame for recruitment and the
necessity to anticipate the variability of contexts
possibly given later when the intervention might
be delivered in routine care.
 2. An active control intervention is applied, since
a consultation on how to deal with the conse-
quences of the disease is normal in outpatient
dementia care in Germany and the WHEDA-study
aims at the evaluation of potential effects addi-
tional to standard care. Furthermore waiting group
control conditions may lead to disappointment
and feelings of neglect in the waiting group after
randomisation and may enhance the contrast
between intervention and waiting group.
 3. The follow-up period is prolonged from 12
weeks in the Dutch trial to 26 weeks in the
WHEDA study, in order to assess the long-term
treatment potential to reduce the negative conse-
WHEDA flow chart (planned progress)Figure 1
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ing. The additional one-year follow-up intends to
evaluate the impact of interventions on the inci-
dence of nursing home placements.
 4. The Assessment of Motor and Process Skills
(AMPS) used in the original Dutch study was
replaced by the PRPP, since AMPS was not availa-
ble in Germany and the PRPP shows better feasi-
bility. Since PRPP pilot data are not available, the
power calculation was based on the IDDD.
 5. The 14 German occupational therapists with a
minimum of one year's experience in the treat-
ment of people who are cognitively impaired,
undertook a 16 hours post-graduate skills training
course and exercise their skills in training on the
job for about 35 hours within the WHEDA pilot
phase. The two Dutch occupational therapists had
four years experience in the treatment of people
who were cognitively impaired and each had 240
hours of experience in treatment according to the
guidelines after post-graduate skill training course
of 80 hours. The WHEDA recruitment period of
nine months is shorter than in the Dutch trial
which had three years and nine months recruit-
ment time. The reduced recruitment period, the
extended number of involved therapists and the
shortened seminar time all match routine condi-
tions, which would be found in an implementa-
tion of standard dementia care.
 6. The WHEDA study does not determine stable
medication for people with dementia as inclusion
criteria, since changes in medication are common
in dementia care. In contrast to the Dutch original
trial, the WHEDA study is kept open to patients,
for whom occupational therapy goals cannot be
defined before the start of the treatment. This is
congruent to the routine situation, since German
physicians cannot explore possible occupational
therapy goals before prescribing this treatment.
According to the arguments listed above, effects as
revealed by the Dutch original study may be reduced in
the multi-centre prolonged WHEDA design. For this rea-
son, the statistical power was calculated conservatively
and a process evaluation assessing variations in settings
and delivery processes as well as treatment fidelity and
adherence to therapeutic recommendations was planned.
Adjusted analyses considering the variations in settings,
structures and processes should be able to provide expla-
nations for outcomes differing between the Dutch origi-
nal study and the German replication.
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